DSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk

Dow Jones2025-12-30

0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. "Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced," he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com)

(END) Dow Jones Newswires

December 30, 2025 02:56 ET (07:56 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2595076789?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-30 15:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595076789","market":"fut","top_or_hot":-1,"title":"DSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 30, 2025 02:56 ET (07:56 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDSM-Firmenich Could Keep Minority Stake in Vitamins, Animal-Nutrition Businesses -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-30 15:56</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 30, 2025 02:56 ET (07:56 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DSM","symbol_name":"Dreyfus Strategic Municipal Bond","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2595076789","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595076789","pubTimestamp":1767081360,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DSM":"Dreyfus Strategic Municipal Bond"},"translate_title":"帝斯曼芬美意可能保留维生素和动物营养业务的少数股权——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DSM":1.5},"content_text":"0756 GMT - DSM-Firmenich's failure to sell its vitamins and animal-nutrition businesses by year-end indicates difficult discussions with private-equity buyers, Berenberg analyst Sebastian Bray writes. Any deal is now likely to result in DSM keeping a roughly 35% stake in the businesses, which could still boost the company's share price, Bray says. \"Even if DSM-Firmenich's remaining stake proves difficult to monetize, we suspect the market reaction will be to sigh with relief that the level of volatility associated with the business has been reduced,\" he says. Shares closed Monday at 69.02 euros and have fallen 29% over the year to date. (ian.walker@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 30, 2025 02:56 ET (07:56 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2595076789","isCrawlerRequest":true}